Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Guglin, Maya
REBIRTH, NCT05180773: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Recruiting	4	250	US	Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo	Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)	Peripartum Cardiomyopathy, Postpartum	06/26	12/28
HF2 Registry, NCT06425848: - Hemodynamic Frontiers in Heart Failure Registry	Recruiting	N/A	2000	US	Observational	University of Kansas Medical Center	Heart Failure	12/30	12/30
Campbell, Ken S
NCT00753974: Cardiovascular Biorepository	Enrolling by invitation	N/A	1000	US		Kenneth S. Campbell	Cardiovascular Diseases	06/27	06/27